it appears that some alteration in vasculature, either related primarily to what causes IDB, or secondary relation to presence of inflammation, does provide from 1.3 to 3.6 fold increase in chances of TE (thrombotic event) for IBD patients. while significant, this is still a small percentage of IBD patients. Still, a larger than expected number of IBD patients are hypercoagulable; and this needs research attention. Possibly some changes to standard of care in hospitals too.
Most of the evidence is veneous (e.g., deep vein thrombosis), but some evidence is arterial. Interestingly however most IBD patients do not have the usual genetic risk factors for arterial disease.
no special prophylactic thrombotic guidelines for IBD patients have been developed, but standard measures (mobility, massage) make sense. I read that any IBD patient that has had TE complications should be considered for Wafarin.
A recent 2013 review compared recent attention to TE in IBD to attention TE has gotten tin rumatoid disease.
conclusion of review said...
There is incontrovertible evidence that patients with IBD are at considerably increased risk of VTE and emerging evidence that the risk of arterial disease may be increased despite the likely reduced presence of standard risk factors. There are currently apparent gaps between this knowledge and clinical therapeutic action to prevent TE events. In rheumatology, the contribution of cardiovascular disease to morbidity and mortality was not recognized for many decades, but attention to risk factors and more aggressive control the disease is now standard of care. It is possible that the same evolution of clinical practice will occur in patients with IBD. Perhaps vascular disease is the sleeping giant of IBD.
Title: Venous and arterial disease in inflammatory bowel disease
Author(s): Tan, Victoria P.; Chung, Alvin; Yan, Bryan P.; et al.
Source: JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Volume: 28 Issue: 7 Pages: 1095-1113 DOI: 10.1111/jgh.12260 Published: JUL 2013